PEAK6 Investments’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$360K Buy
+3,664
New +$473K ﹤0.01% 2502
2023
Q4
Sell
-40
Closed -$17.8K 4155
2023
Q3
$17.8K Sell
40
-424
-91% -$192K ﹤0.01% 3772
2023
Q2
$201K Buy
+464
New +$261K ﹤0.01% 2868
2022
Q3
Sell
-464
Closed -$201K 4869
2022
Q2
$201K Sell
464
-788
-63% -$399K ﹤0.01% 4756
2022
Q1
$793K Buy
+1,252
New +$645K ﹤0.01% 2712
2021
Q4
Sell
-612
Closed -$401K 5034
2021
Q3
$401K Buy
+612
New +$523K ﹤0.01% 3432

Other funds holding AGL

PEAK6 Investments's AGL Position: Q3 2024 in Review

PEAK6 Investments opened a new position in Agilon Health (AGL) in Q3 2024: 1,170 shares worth $115K. The stake represents ﹤0.01% of the portfolio and ranks #2953 among its holdings. This is a return to the name: PEAK6 Investments previously reported a position in AGL as recently as Q3 2023.

PEAK6 Investments first reported a position in AGL in Q4 2021 and has held it in 6 quarters since. The position peaked at $340K in Q3 2023. 209 funds tracked by Wall St. Rank hold AGL as of Q3 2024.

  • PEAK6 Investments held 1,170 shares of Agilon Health worth $115K as of Q3 2024.
  • Agilon Health was a new PEAK6 Investments position in Q3 2024.
  • Agilon Health made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2953 holding.
  • PEAK6 Investments first reported a position in Agilon Health in Q4 2021 and has held it in 6 quarters since.
  • PEAK6 Investments's Agilon Health position peaked at $340K in Q3 2023.
  • 209 funds tracked by Wall St. Rank held Agilon Health as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.